Literature DB >> 11891438

Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus.

Naoki Otani1, Hiroshi Nawashiro, Shinji Fukui, Namiko Nomura, Akiko Yano, Takahito Miyazawa, Katsuji Shima.   

Abstract

Mitogen-activated protein kinases, which play a crucial role in signal transduction, are activated by phosphorylation in response to a variety of mitogenic signals. In the present study, the authors used Western blot analysis and immunohistochemistry to show that phosphorylated extracellular signal-regulated protein kinase (p-ERK) and c-Jun NH2-terminal kinase (p-JNK), but not p38 mitogen-activated protein kinase, significantly increased in both the neurons and astrocytes after traumatic brain injury in the rat hippocampus. Different immunoreactivities of p-ERK and p-JNK were observed in the pyramidal cell layers and dentate hilar cells immediately after traumatic brain injury. Immunoreactivity for p-JNK was uniformly induced but was only transiently induced throughout all pyramidal cell layers. However, strong immunoreactivity for p-ERK was observed in the dentate hilar cells and the damaged CA3 neurons, along with the appearance of pyknotic morphologic changes. In addition, immunoreactivity for p-ERK was seen in astrocytes surrounding dentate and CA3 pyramidal neurons 6 hours after traumatic brain injury. These findings suggest that ERK and JNK but not p38 cascades may be closely involved in signal transduction in the rat hippocampus after traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891438     DOI: 10.1097/00004647-200203000-00010

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  22 in total

1.  Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.

Authors:  Ying-Liang Liu; Zhi-Ming Xu; Guo-Yuan Yang; Dian-Xu Yang; Jun Ding; Hao Chen; Fang Yuan; Heng-Li Tian
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

Review 2.  Oxidative neuronal injury. The dark side of ERK1/2.

Authors:  Charleen T Chu; David J Levinthal; Scott M Kulich; Elisabeth M Chalovich; Donald B DeFranco
Journal:  Eur J Biochem       Date:  2004-06

Review 3.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

4.  Immunohistochemical analysis of histone H3 acetylation and methylation--evidence for altered epigenetic signaling following traumatic brain injury in immature rats.

Authors:  Wei-Min Gao; Mandeep S Chadha; Anthony E Kline; Robert S B Clark; Patrick M Kochanek; C Edward Dixon; Larry W Jenkins
Journal:  Brain Res       Date:  2006-01-09       Impact factor: 3.252

5.  Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Authors:  Hien T Tran; Laura Sanchez; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

6.  Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1α) attenuates traumatic brain injury in rats.

Authors:  Weifeng Sun; Jiafeng Liu; Yu Huan; Chaodong Zhang
Journal:  Inflamm Res       Date:  2013-12-19       Impact factor: 4.575

7.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 8.  Signaling from P2 nucleotide receptors to protein kinase cascades induced by CNS injury: implications for reactive gliosis and neurodegeneration.

Authors:  Joseph T Neary; Yuan Kang
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

9.  Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Linda Nguyen; Rae R Matsumoto; Ryan C Turner; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2016-04-27       Impact factor: 3.252

10.  Non-receptor tyrosine kinase Src is required for ischemia-stimulated neuronal cell proliferation via Raf/ERK/CREB activation in the dentate gyrus.

Authors:  He-Ping Tian; Bao-Sheng Huang; Jie Zhao; Xiao-Han Hu; Jun Guo; Li-Xin Li
Journal:  BMC Neurosci       Date:  2009-11-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.